These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8258321)

  • 1. Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing.
    Ossevoort MA; Sijts AJ; van Veen KJ; Momburg F; Hämmerling GJ; Seelig A; Butcher GW; Howard JC; Kast WM; Melief CJ
    Eur J Immunol; 1993 Dec; 23(12):3082-8. PubMed ID: 8258321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes.
    Zhou X; Glas R; Momburg F; Hämmerling GJ; Jondal M; Ljunggren HG
    Eur J Immunol; 1993 Aug; 23(8):1796-801. PubMed ID: 8393798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter.
    Aldrich CJ; Waltrip R; Hermel E; Attaya M; Lindahl KF; Monaco JJ; Forman J
    J Immunol; 1992 Dec; 149(12):3773-7. PubMed ID: 1460275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ham-2 corrects the class I antigen-processing defect in RMA-S cells.
    Attaya M; Jameson S; Martinez CK; Hermel E; Aldrich C; Forman J; Lindahl KF; Bevan MJ; Monaco JJ
    Nature; 1992 Feb; 355(6361):647-9. PubMed ID: 1538753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing.
    Gabathuler R; Reid G; Kolaitis G; Driscoll J; Jefferies WA
    J Exp Med; 1994 Oct; 180(4):1415-25. PubMed ID: 7931074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes.
    Zhou X; Liu T; Franksson L; Lederer E; Ljunggren HG; Jondal M
    Scand J Immunol; 1995 Jul; 42(1):66-75. PubMed ID: 7631147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter.
    Powis SJ; Townsend AR; Deverson EV; Bastin J; Butcher GW; Howard JC
    Nature; 1991 Dec 19-26; 354(6354):528-31. PubMed ID: 1758495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity of MHC-encoded peptide transporters from human, mouse and rat.
    Momburg F; Roelse J; Howard JC; Butcher GW; Hämmerling GJ; Neefjes JJ
    Nature; 1994 Feb; 367(6464):648-51. PubMed ID: 8107849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
    Salazar-Onfray F; Charo J; Petersson M; Freland S; Noffz G; Qin Z; Blankenstein T; Ljunggren HG; Kiessling R
    J Immunol; 1997 Oct; 159(7):3195-202. PubMed ID: 9317117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation.
    Schirmbeck R; Reimann J
    Eur J Immunol; 1994 Jul; 24(7):1478-86. PubMed ID: 8026512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.
    Hosken NA; Bevan MJ
    J Exp Med; 1992 Mar; 175(3):719-29. PubMed ID: 1311017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter.
    Yewdell JW; Esquivel F; Arnold D; Spies T; Eisenlohr LC; Bennink JR
    J Exp Med; 1993 Jun; 177(6):1785-90. PubMed ID: 8496691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation.
    Momburg F; Ortiz-Navarrete V; Neefjes J; Goulmy E; van de Wal Y; Spits H; Powis SJ; Butcher GW; Howard JC; Walden P
    Nature; 1992 Nov; 360(6400):174-7. PubMed ID: 1299222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocytes against the antigen-processing-defective RMA-S tumor cell line.
    Sijts AJ; De Bruijn ML; Nieland JD; Kast WM; Melief CJ
    Eur J Immunol; 1992 Jun; 22(6):1639-42. PubMed ID: 1601045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the mouse Tap-1 gene. Association with abnormal CD8+ T cell development in the nonobese nondiabetic mouse.
    Pearce RB; Trigler L; Svaasand EK; Peterson CM
    J Immunol; 1993 Nov; 151(10):5338-47. PubMed ID: 8228229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermolabile H-2Kb molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides.
    De Silva AD; Boesteanu A; Song R; Nagy N; Harhaj E; Harding CV; Joyce S
    J Immunol; 1999 Oct; 163(8):4413-20. PubMed ID: 10510382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonclassical behavior of the thymus leukemia antigen: peptide transporter-independent expression of a nonclassical class I molecule.
    Holcombe HR; Castaño AR; Cheroutre H; Teitell M; Maher JK; Peterson PA; Kronenberg M
    J Exp Med; 1995 Apr; 181(4):1433-43. PubMed ID: 7699328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.